Compare BME & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BME | PRME |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.7M | 601.1M |
| IPO Year | N/A | 2022 |
| Metric | BME | PRME |
|---|---|---|
| Price | $40.79 | $4.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.31 |
| AVG Volume (30 Days) | 34.0K | ★ 3.8M |
| Earning Date | 01-01-0001 | 11-07-2025 |
| Dividend Yield | ★ 6.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | N/A | ★ $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $28.37 | ★ N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $35.53 | $1.11 |
| 52 Week High | $43.20 | $6.94 |
| Indicator | BME | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | 49.51 |
| Support Level | $39.81 | $3.95 |
| Resistance Level | $40.67 | $4.42 |
| Average True Range (ATR) | 0.43 | 0.31 |
| MACD | -0.11 | 0.10 |
| Stochastic Oscillator | 64.42 | 65.09 |
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.